Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Smyth

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|December 25, 2025
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UKRobert A Watson, Darcy Ward, Pippa Corrie, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 30, 2020
Telehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemicMairead O'Donovan, Catherine Buckley, Julie Benson, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 5, 2026
ISDE guidelines on the management of cT2N0 esophageal cancerGeoffrey P Kohn, Virginia Litle, Yousif Eliya, et al.
Journal of Gastrointestinal Oncology|January 12, 2026
Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United KingdomJoseph Salf, Aimee Cunningham, Dinakshi Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinomaManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
Cancer Discovery|May 15, 2016
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical TrialAlex Pearson, Elizabeth Smyth, Irina S Babina, et al.
Familial Cancer|June 19, 2008
Predicting breast cancer risk: implications of a "weak" family historyElaine Anderson, Jonathan Berg, Roger Black, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO GuidelineManish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|December 25, 2025
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UKRobert A Watson, Darcy Ward, Pippa Corrie, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 30, 2020
Telehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemicMairead O'Donovan, Catherine Buckley, Julie Benson, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 5, 2026
ISDE guidelines on the management of cT2N0 esophageal cancerGeoffrey P Kohn, Virginia Litle, Yousif Eliya, et al.
Journal of Gastrointestinal Oncology|January 12, 2026
Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United KingdomJoseph Salf, Aimee Cunningham, Dinakshi Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2019
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinomaManfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
Cancer Discovery|May 15, 2016
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical TrialAlex Pearson, Elizabeth Smyth, Irina S Babina, et al.
Familial Cancer|June 19, 2008
Predicting breast cancer risk: implications of a "weak" family historyElaine Anderson, Jonathan Berg, Roger Black, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO GuidelineManish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Pageof 9